\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ biopsy\ \(441\)\
\-\ radiation\ \(402\)\
\-\ no\\ progression\\ of\\ disease\\ over\\ past\\ 5\\ years\ \(0\)\
\-\ \\â\\€\\¢\\ skull\\ base\\ complex\\ mass\\ extending\\ into\\ sella\\ and\\ suprasellar\\ cistern\\.\ \(0\)\
\-\ \\â\\€\\¢\\ irregular\\ enhancement\\ on\\ mri\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mottled\\ calcification\\ noted\\ within\\ mass\\ on\\ ct\ \(0\)\
\-\ chondrosarcoma\\ of\\ skull\\ base\ \(0\)\
\-\ \\â\\€\\¢\\ chondrosarcoma\ \(3\)\
\-\ \\â\\€\\¢\\ craniopharyngioma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ chordoma\ \(1\)\
\-\ 17\\ year\\ old\\ boy\\ presents\\ with\\ headache\\ and\\ progressive\\ visual\\ loss\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.19286330481180158\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.1314530351291229\ \(0\)\
\-\ skull\\:\\ 0\\.11198057511977444\ \(0\)\
\-\ base\\:\\ 0\\.1029987163948113\ \(0\)\
\-\ mottled\\:\\ 0\\.09115610255492822\ \(0\)\
\-\ chordoma\\:\\ 0\\.0861021938322815\ \(0\)\
\-\ sella\\:\\ 0\\.07574920193624418\ \(0\)\
\-\ suprasellar\\:\\ 0\\.07164054370164348\ \(0\)\
\-\ cistern\\:\\ 0\\.07026189510641753\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.0696162920433555\ \(0\)\
\-\ progression\\:\\ 0\\.06540261896151789\ \(0\)\
\-\ 17\\:\\ 0\\.06402397036629193\ \(0\)\
\-\ visual\\:\\ 0\\.059598092328572216\ \(0\)\
\-\ complex\\:\\ 0\\.05264447504021749\ \(0\)\
\-\ irregular\\:\\ 0\\.052436102346252\ \(0\)\
\-\ progressive\\:\\ 0\\.05196060176989697\ \(0\)\
\-\ meningioma\\:\\ 0\\.05055522056084731\ \(0\)\
\-\ calcification\\:\\ 0\\.047719778745494296\ \(0\)\
\-\ biopsy\\:\\ 0\\.046641434486719396\ \(0\)\
\-\ headache\\:\\ 0\\.045153622116396896\ \(0\)\
\-\ boy\\:\\ 0\\.044688027383476485\ \(0\)\
\-\ available\\:\\ 0\\.04419567767445842\ \(0\)\
\-\ extending\\:\\ 0\\.04419567767445842\ \(0\)\
\-\ radiation\\:\\ 0\\.04314232691634364\ \(0\)\
\-\ disease\\:\\ 0\\.04297653972971398\ \(0\)\
\-\ past\\:\\ 0\\.04177229956840668\ \(0\)\
\-\ years\\:\\ 0\\.03860374056951512\ \(0\)\
\-\ 5\\:\\ 0\\.038464006499140974\ \(0\)\
\-\ loss\\:\\ 0\\.03816098726874523\ \(0\)\
\-\ mass\\:\\ 0\\.03656803098300199\ \(0\)\
\-\ enhancement\\:\\ 0\\.03523828870958517\ \(0\)\
\-\ over\\:\\ 0\\.03347142446369173\ \(0\)\
\-\ metastatic\\:\\ 0\\.03309399082486293\ \(0\)\
\-\ into\\:\\ 0\\.03128194412245703\ \(0\)\
\-\ noted\\:\\ 0\\.03116032597619375\ \(0\)\
\-\ mri\\:\\ 0\\.030204243921763383\ \(0\)\
\-\ presents\\:\\ 0\\.026856066084737323\ \(0\)\
\-\ within\\:\\ 0\\.025078944744401258\ \(0\)\
\-\ on\\:\\ 0\\.02227356961124394\ \(0\)\
\-\ not\\:\\ 0\\.018997210334491314\ \(0\)\
\-\ ct\\:\\ 0\\.0183892869752622\ \(0\)\
\-\ year\\:\\ 0\\.01470931183496792\ \(0\)\
\-\ old\\:\\ 0\\.013460532259419303\ \(0\)\
\-\ no\\:\\ 0\\.013237602318520031\ \(0\)\
\-\ and\\:\\ 0\\.0055387386379144145\ \(0\)\
\-\ of\\:\\ 0\\.003584732332245798\ \(0\)\
\-\ with\\:\\ 0\\.0018000642475367653\ \(0\)\
\-\ \\.\\:\\ 0\\.001638440127569828\ \(0\)\
